Hyaluronic acid treatments are well known and have long been widely used in the skin, to treat general wounds, ulcers and burns. Fidia has developed a unique and exclusive portfolio, based on high-tech, hyaluronan bioactive treatments to manage acute and chronic lesions, a disabling condition that is becoming increasingly common, as life expectancy lengthens, and can negatively affect an individual’s quality of life.

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.